DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,300,519 | +6.4% | 17,334 | +2.9% | 2.17% | +12.0% |
| Q2 2023 | $4,042,463 | -0.5% | 16,844 | +4.5% | 1.94% | -7.9% |
| Q1 2023 | $4,063,733 | -3.6% | 16,123 | +1.5% | 2.10% | -0.6% |
| Q4 2022 | $4,216,507 | +0.8% | 15,886 | -1.9% | 2.12% | -10.2% |
| Q3 2022 | $4,183,000 | +1.4% | 16,196 | -0.4% | 2.36% | +10.6% |
| Q2 2022 | $4,124,000 | -13.7% | 16,266 | -0.1% | 2.13% | -8.8% |
| Q1 2022 | $4,777,000 | -11.4% | 16,286 | -0.7% | 2.34% | -9.4% |
| Q4 2021 | $5,394,000 | +8.1% | 16,393 | 0.0% | 2.58% | -2.8% |
| Q3 2021 | $4,991,000 | +14.3% | 16,393 | +0.7% | 2.65% | +9.5% |
| Q2 2021 | $4,367,000 | +27.7% | 16,273 | +7.1% | 2.42% | +14.4% |
| Q1 2021 | $3,419,000 | +4.8% | 15,188 | +3.4% | 2.12% | -2.7% |
| Q4 2020 | $3,263,000 | +3.2% | 14,688 | 0.0% | 2.17% | -15.4% |
| Q3 2020 | $3,163,000 | +19.9% | 14,688 | -1.5% | 2.57% | +20.7% |
| Q2 2020 | $2,637,000 | +34.5% | 14,914 | +5.3% | 2.13% | +5.9% |
| Q1 2020 | $1,960,000 | -4.4% | 14,158 | +5.9% | 2.01% | +21.5% |
| Q4 2019 | $2,051,000 | – | 13,363 | – | 1.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 232,593 | $60,115,000 | 16.52% |
| Defender Capital, LLC. | 139,231 | $35,988,000 | 14.10% |
| Third Point | 2,700,000 | $697,383,000 | 12.60% |
| Riverstone Advisors, LLC | 62,416 | $16,121,000 | 10.38% |
| Eos Focused Equity Management, L.P. | 32,304 | $8,344,000 | 9.87% |
| Alphinity Investment Management Pty Ltd | 1,185,235 | $306,134,000 | 9.81% |
| AGF Investments America Inc. | 88,205 | $22,782,000 | 8.41% |
| Front Street Capital Management, Inc. | 117,802 | $30,427,000 | 7.70% |
| CORTLAND ASSOCIATES INC/MO | 164,142 | $42,396,000 | 7.55% |
| THAMES CAPITAL MANAGEMENT LLC | 57,156 | $14,763,000 | 7.33% |